Table 3.

Hazard ratios of diabetes incidence comparing individual angiotensin receptor blocker with losartan

	Valsartan	Irbesartan	Candesartan	Telmisartan	Olmesartan
All subjects
Crude	0.99 (0.97-1.01)	0.95 (0.93-0.97)	1.13 (1.09-1.17)	0.98 (0.95-1.01)	1.35 (1.29-1.40)
Multivariable regression analysis	1.01 (0.99-1.03)	0.99 (0.97-1.02)	0.99 (0.96-1.03)	0.99 (0.96-1.03)	1.07 (1.03-1.12)
Multivariable regression adjusted for mean daily dosage	1.01 (0.99-1.03)	0.99 (0.97-1.01)	0.99 (0.96-1.02)	0.99 (0.96-1.02)	1.07 (1.03-1.12)
Excluding those followed for less than one year
Crude	1.00 (0.98-1.02)	0.97 (0.94-0.99)	1.18 (1.14-1.23)	1.00 (0.96-1.03)	1.48 (1.41-1.55)
Multivariable regression analysis	1.02 (1.00-1.04)	1.01 (0.98-1.03)	1.00 (0.96-1.04)	1.00 (0.96-1.03)	1.09 (1.04-1.14)
Multivariable regression adjusted for mean daily dosage	1.02 (1.00-1.04)	1.00 (0.98-1.03)	0.99 (0.96-1.03)	1.00 (0.96-1.03)	1.09 (1.05-1.14)

Multivariable regression analysis: adjusted for baseline covariates by traditional multivariable regression with stepwise variable selection.